Company: CRL
Filing Date: 2025-02-19
Form Type: 10-K
Source: 0001100682-25-000011
Chunk: 183

Company: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Filing Date: 2025-02-19
Form: 10-K
Item: Item 8
Chunk 183
---
 in accumulated other comprehensive loss related to the Company’s pension, DCP, and ESLIRP plans are as follows:Fiscal Year 202420232022(in thousands)Net actuarial loss$69,340 $58,855 $54,509 Net prior service cost (credit)(125)(121)(585)Net amount recognized$69,215 $58,734 $53,924 The accumulated benefit obligation and fair value of plan assets for the Company’s pension, DCP, and ESLIRP plans with accumulated benefit obligations in excess of plan assets are as follows: December 28, 2024December 30, 2023(in thousands)Accumulated benefit obligation$59,920 $54,310 Fair value of plan assets2,901 2,824 

93

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

The projected benefit obligation and fair value of plan assets for the Company’s pension, DCP, and ESLIRP plans with projected benefit obligations in excess of plan assets are as follows: December 28, 2024December 30, 2023(in thousands)Projected benefit obligation$68,487 $61,671 Fair value of plan assets3,548 3,496 Components of total benefit cost for the Company’s pension, DCP, and ESLIRP plans are as follows:Fiscal Year 202420232022(in thousands)Service cost$2,807 $2,474 $3,213 Interest cost10,417 9,941 6,140 Expected return on plan assets(7,077)(7,556)(7,322)Amortization of prior service credit4 (464)(506)Amortization of net loss1,632 1,231 2,869 Net periodic benefit cost7,783 5,626 4,394 Settlement— — 981 Total benefit cost$7,783 $5,626 $5,375 AssumptionsWeighted-average assumptions used to determine projected benefit obligations are as follows: December 28, 2024December 30, 2023Discount rate5.2 %4.7 %Rate of compensation increase3.2 %3.2 %The discount rate reflects the rate the Company would have to pay to purchase high-quality investments that would